UK Supports End-To-End Management Of Trials Undergoing Combined Reviews
Ongoing efforts by the UK to deliver a single decision on the ethical and regulatory approval of new clinical trial applications have reached a major milestone ahead of the 2022 mandatory deadline.
You may also be interested in...
Having gained enough experience with the combined ethics and regulatory review of clinical trial applications, the UK will make this its only route for evaluating new drug trial applications starting next year.
The European Medicines Agency is inviting feedback from organizations interested in delivering a training program to the members of the European medicines regulatory network to improve their big data analysis and assessment skills.
The UK has started monitoring whether clinical trial sponsors are fulfilling responsibilities to make their research open and transparent.